During the past decade, University of Pennsylvania, Department of Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Pennsylvania, Department of Neurology" #1 sponsor was "Avanir Pharmaceuticals" with 2 trials, followed by "TauRx Therapeutics Ltd" with 2 trials sponsored, "Novartis" with 1 trials sponsored, "Revance Therapeutics, Inc." with 1 trials sponsored and "Sunovion" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pennsylvania, Department of Neurology" #1 collaborator was "Syneos Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Pennsylvania, Department of Neurology" are "Alzheimer's Disease" (2 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Behavioral Variant Frontotemporal Dementia" (1 trials), "Behavioral Variant Frontotemporal Dementia (bvFTD)" (1 trials) and "Cervical Dystonia" (1 trials). Many other conditions were trialed in "University of Pennsylvania, Department of Neurology" in a lesser frequency.

Most popular intervention types in "University of Pennsylvania, Department of Neurology" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AVP-923" (2 trials), "DaxibotulinumtoxinA for injection" (1 trials), "Fingolimod" (1 trials) and "LMTM" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Pennsylvania, Department of Neurology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "University of Pennsylvania, Department of Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University of Pennsylvania, Department of Neurology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Pennsylvania, Department of Neurology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".